Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.(Endocrinology), M.R.C.P (UK), MRCPE (UK)
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.(Endocrinology), M.R.C.P (UK), MRCPE (UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCP(UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCP (UK)
Consultant Physician
M.B.B.S, M.D (USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Gastroenterologist
MBBS, Diplomate of American Board (Internal Medicine - USA), Diplomate of American Board (Gastroenterology - USA)
Gastroenterologist
MBBS, Diplomate of American Board (Internal Medicine - USA), Diplomate of American Board (Gastroenterology - USA)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures